您要查找的是不是：
- Kupffer cell medium 枯否細胞介質(zhì)
- There is lobular disarray with focal hepatocyte necrosis, giant cell transformation, lymphocytic infiltration, Kupffer cell hyperplasia, and cholestasis (not seen here). 圖中可見(jiàn)具有病灶肝細胞壞死、巨細胞轉化、淋巴細胞浸潤、枯否細胞增生和膽汁淤積（此圖未顯示）的肝小葉紊亂。
- On the contrary, the prominent features in liver section of the RC group were inflammatory cell (notably mononuclear) infiltration and Kupffer cell activation. RC組炎癥反應較突出，主要為單核細胞浸潤以及枯否細胞活躍，大滋養體和裂殖體在肝血竇滯留；
- Furthermore, TG1-1 cell medium supplemented with estrogen-induced BM-EPC mediated tubulogenesis, which was an experimental in vivo representation of the neovasculature. 細胞水平的分析顯示雌二醇可以刺激骨髓源性?xún)绕ぜ毎婕毎ㄟ^(guò)旁分泌作用刺激TG1-1增生和遷移。
- The hepatocytes and Kupffer cells here are full of granular brown deposits of hemosiderin from accumulation of excess iron in the liver. 圖中肝細胞和枯否細胞內充滿(mǎn)由肝臟中過(guò)多的鐵積聚造成的含鐵血黃素的褐色粒狀沉著(zhù)。
- Objective To observe the synthesis of TLR2 protein and mRNA expression in Kupffer cells(KCs). 目的 觀(guān)察小鼠肝部分缺血 /再灌注損傷時(shí)肝臟Kupffer細胞表面TLR2mRNA的表達及蛋白質(zhì)的合成情況。
- A Prussian blue iron stain demonstrates the blue granules of hemosiderin in hepatocytes and Kupffer cells. 普魯士藍鐵染色顯示肝細胞和枯否細胞中含鐵血黃素的藍色顆粒。
- Oligodendrocyte Precursor Cell Medium (OPCM) is a complete medium designed for optimal growth of normal human oligodendrocyte precursor cells in vitro. 少突膠質(zhì)前體細胞培養基是專(zhuān)門(mén)為正常人類(lèi)少突膠質(zhì)前體細胞體外培養設計的最適于其生長(cháng)的培養基。
- Prussian blue iron stain demonstrates the blue granules of hemosiderin in hepatocytes and Kupffer cells. 普魯士藍鐵染色顯示肝細胞和枯否細胞中含鐵血黃素的藍色顆粒。
- Mesenchymal Stem Cell Medium (MSCM) is a complete medium designed for optimal growth of normal human mesenchymal stem cells in vitro. 間充質(zhì)干細胞培養基是專(zhuān)門(mén)為人類(lèi)間充質(zhì)干細胞體外培養所設計的、最適合其生長(cháng)的培養基。
- Meningeal Cell Medium (MCM) is a complete medium designed for optimal growth of normal human brain derived meningeal cells in vitro. 腦膜細胞培養基是專(zhuān)門(mén)為正常人類(lèi)腦膜細胞體外培養設計的最適于其生長(cháng)的培養基。
- Many erythrocyte and kupffer cells were seen in sinusoid of liver and spleen, along with many yellow and brown irons contained blood grains. 大量肝細胞腫脹，胞漿內可見(jiàn)許多大小不一的脂肪空泡；肝細胞胞核濃縮、碎裂、溶解甚至消失。
- CONCLUSION Liver fibrosis was related to the proliferation of both Kupffer cells and lipocytes and their expression of bFGF. 主題詞肝硬變，實(shí)驗性/代謝；成纖維細胞生長(cháng)因子，堿性/代謝；免疫組織化學(xué)
- Urothelila Cell Medium (UCM) is a complete medium designed for optimal growth of normal human urothelial cells in vitro. 尿道上皮細胞培養基是專(zhuān)門(mén)為正常人類(lèi)尿道上皮細胞體外培養設計的最適于其生長(cháng)的培養基。
- Smooth Muscle Cell Medium (SMCM) is a complete medium designed for optimal growth of normal human smooth muscle cells in vitro. 內皮細胞培養基是專(zhuān)門(mén)為正常人類(lèi)微血管內皮細胞體外培養設計的最適于其生長(cháng)的完全培養基。
- A Prussian blue reaction is seen in this iron stain of the liver to demonstrate large amounts of hemosiderin that are present in hepatocytes and Kupffer cells. 肝臟普魯士藍染色顯示,呈藍色的含鐵血黃素顆粒大量沉著(zhù)在肝實(shí)質(zhì)細胞和。
- Prussian blue reaction is seen in this iron stain of the liver to demonstrate large amounts of hemosiderin that are present in hepatocytes and Kupffer cells. 肝臟普魯士藍染色呈藍色的含鐵血黃素顆粒大量沉著(zhù)在肝實(shí)質(zhì)細胞和庫普弗細胞內。
- Cirrhotic Kupffer cells also had increased densities of functional receptors for both PAF and ET-1(exclusively ETB),but did not change the affinity of these receptors. No mRNA transcripts for the ETA receptor or preproET-1 were detected. 肝硬化組Kupffer細胞PAF及ETB受體mRNA水平及受體密度明顯增加,而受體親和力無(wú)變化,無(wú)ETA受體和ppET-1 mRNA表達。
- Objective:To observe the synthesis of Toll-like receptor (TLR)4 protein and its mRNA expression in Kupffer cells (KCs) and evaluate the role of TLR 4 in the liver injury in the rats with alcohol-induced liver disease (ALD). 目的 :觀(guān)察酒精性肝病大鼠Kupffer細胞 (KCs)Toll樣受體 (TLR) 4蛋白合成和基因表達及其在肝損害中的作用。
- Thus,the aim of this study was to characterize the effect on the antigen-presenting function of Kupffer cells by intrasplenic transplantation of GM-CSF gene-modified fetal liver cells (FLC-GM)in combination with IL-2 and 5-Fu. 方法 :以結腸癌肝轉移小鼠為模型 ,以脾內移植GM CSF基因修飾的胎肝細胞 (FLC GM)與低劑量IL 2、5 Fu腹腔注射作為基因治療與化學(xué)免疫治療聯(lián)合應用方案。
